Ccc_R08

• Description:

  Ccc_R08 is an orally available HBV cccDNA inhibitor that reduces extracellular levels of HBV DNA, HBsAg, and HBeAg in a dose-dependent manner. ccc_R08 is investigational for use in the treatment of HBV infections. ccc_R08 has been shown to be effective in the treatment of hepatitis C virus (HCV) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  414.84

• Molecular Formula:

  C22H19ClO6

• Notes:

  Research use only, not for human use.

• Receptor:

  HBV

• CAS Number:

  2919019-72-8